GoldenExo® NCBA

A 50 mL cryopreserved UC-MSC extracellular vesicle bulk material developed as a flexible starting point for formulation screening, process scale-up and professional product-development programs.

Quick Facts

  • Cryopreserved MSC-EV Bulk Material
  • Presentation: Cryopreserved
  • Fill Volume: 50 mL
  • Storage: -80°C
  • Shipping: Dry ice
  • Source: Human UC-MSC
  • COA
  • TDS
  • 50 mL bulk
  • Scale-Up Support

A flexible starting material for formulation screening, specification definition and downstream scale-up.

NCBA is positioned as a native MSC-EV bulk starting material rather than a single fixed application product, leaving room for project-specific formulation, concentration, packaging and process development.

Bulk-Format Flexibility: A 50 mL cryopreserved presentation supports formulation screening and multi-batch development work.

Native MSC-EV Material: Provides a broad signaling base for professional repair, firming and healthy-aging formulation research.

Process-Development Fit: Suitable for concentration, buffer exchange, blending, filling and downstream-format feasibility.

GMP-Oriented Collaboration: Can connect with analytical testing, formulation development and entrusted manufacturing programs.

Evaluation pathway designed around product use

01 Source & Cell Bank: Confirm source, cell identity and batch traceability.

02 Culture & Harvest: Control culture system and harvest window by product positioning.

03 Purification & Concentration: Match purification strategy to lyophilized, frozen or formulation-development needs.

04 Fill & Storage: Define specification, packaging and shipping conditions.

05 Quality Evaluation: Combine EV identity, purity, safety and functional tests by project.

06 Application Support: Connect to formulation, delivery, model validation and co-development.

Quality Connection from Bulk Material to Scale-Up Development

Source Identity & Traceability: Documented human UC-MSC or defined producer-cell sourcing; Cell-bank identity and batch records; Project-appropriate traceability and source controls

Controlled Manufacturing: Defined culture, harvest and purification workflows; Lyophilized or cryopreserved presentation by product design; Batch consistency and scale-up compatibility

Orthogonal Quality Evaluation: Particle concentration, size and EV identity; Purity, membrane integrity and safety tests; Functional or stability assays selected by project

Batch-Level Documentation: COA, TDS and SDS supplied by project scope; Connection to formulation development and further manufacturing; Support for technical review and collaboration planning

Product-specific analytical focus: Projects may confirm particle concentration, EV identity, freeze-thaw stability, formulation compatibility, microbial safety, impurity control and scale-up batch consistency.

Where the Product Can Fit

Formulation Screening: Compare excipients, concentrations and application formats using a common bulk starting material.

Scale-Up Feasibility: Support pilot work before defining final fill volume, concentration and packaging.

Product Upgrades: Use as an EV base material for premium formulation or portfolio-development programs.

Custom Manufacturing: Transition successful prototypes into project-specific OEM, ODM or CDMO pathways.

Key Information for Technical Evaluation

Product Name: GoldenExo® NCBA

Material Type: UC-MSC-derived extracellular vesicle / exosome bulk material

Presentation: Cryopreserved

Fill Volume: 50 mL

Storage: -80°C

Shipping: Dry ice

Application: Formulation screening, process scale-up, product development and further manufacturing

Collaboration: Buffer exchange, concentration adjustment, lyophilization, aseptic filling and packaging development

The current page emphasizes the bulk presentation. Project-specific concentration and particle-content requirements should be confirmed in the quotation and batch documentation.

From Product Supply to Co-Development

Standard Material Supply: Deliver material and agreed documentation according to product specification.

Formulation & Delivery Development: Evaluate concentration, excipients, packaging and application format.

Quality & Stability Research: Extend analytics, stability and model validation by project.

OEM / ODM / CDMO: Connect raw material, prototype and further manufacturing collaboration.

FAQ

What is GoldenExo® NCBA?
NCBA is a 50 mL cryopreserved UC-MSC extracellular vesicle bulk material for formulation screening, product development and further manufacturing.
Is a fixed particle count listed for the 50 mL format?
The current page emphasizes the bulk presentation. Project-specific concentration and particle-content requirements should be confirmed in the quotation and batch documentation.
Can NCBA be converted into a lyophilized or smaller-fill product?
Yes. Buffer exchange, concentration adjustment, lyophilization, aseptic filling and packaging can be evaluated as custom development activities.
How should NCBA be shipped and stored?
The standard cryopreserved presentation is shipped on dry ice and stored at the specified frozen condition, while minimizing freeze-thaw cycles.